AROUND THE INDUSTRY
US FDA Outlines Wishlist For Decentralized Clinical Trials
Clinical Trial Sponsors Should Consider Changing Data Collection Amid COVID-19, US FDA Says. (March 18, 2020) READ MORE …
AROUND THE INDUSTRY
FDA: Clinical Trial Sponsors Should Consider Changing Data Collection Amid COVID-19 Response
Maintaining the safety of clinical trial participants amid COVID-19 and beyond The MyOwnMed ECOS System dovetails with the FDA’s guidance released mid-March, 2020. Let us know if your institution could benefit from a tour of the ECOS Platform.